We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Follow-Up Study Investigates Progression of Vascular Plaque

By MedImaging International staff writers
Posted on 28 Jun 2017
Image: A new follow-up study will investigate the progression of vascular atherosclerotic plaque in patients from a previous study (Photo courtesy of Philips Healthcare).
Image: A new follow-up study will investigate the progression of vascular atherosclerotic plaque in patients from a previous study (Photo courtesy of Philips Healthcare).
A new large-scale study in the US that will investigate the progression of vascular atherosclerotic plaque in patients from a larger, previous study is slated to begin.

The new study will look at disease progression in at least 1,000 patients from a previous study that recruited 7,687 participants between the years 2008 and 2009. Researchers in the previous study used a novel ultrasound imaging method to identify atherosclerotic plaque disease in carotid arteries, and studied how this could affect the risk of the participants developing a heart attack or stroke.

The start of the new BioImage-2 study in Florida and Illinois was announced by the Mount Sinai Hospital (ISMMS; New York, NK, USA) and BioImage-2 (Lexington, MA, USA). The study will begin in September 2017 and continue for one year. The study is intended to promote research into carotid ultrasound imaging methods that can help clinicians decide how best to prevent heart attacks and strokes. The new study is intended to develop and test tools for bringing such imaging techniques into routine clinical practice and provide tailored preventive therapies.

Principal investigator of the BioImage-2 study, Director of Mount Sinai Heart, and Physician-in-Chief, Valentin Fuster, MD, said "Today a broad range of options exist for prevention of atherosclerotic vessel disease, which may lead to heart attack and stroke. If we can identify and characterize subclinical disease early and monitor this over the years, this may one day help us to better identify those who stand to gain most from the intensive preventive therapy options now available."

X-Ray Generator
Advantage Plus Generators
MRI System
nanoScan MRI 3T/7T
Multi-Use Ultrasound Table
Clinton
X-ray Diagnostic System
FDX Visionary-A

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.